Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mroz

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Physics in Medicine and Biology|December 19, 2024
The textures of sarcoidosis: quantifying lung disease through variogramsWilliam L Lippitt, Lisa A Maier, Tasha E Fingerlin, et al.
Patterns (New York, N.Y.)|April 20, 2026
Organizing across disciplines to tackle shared computational challengesWojtek Treyde, Aleksy Kwiatkowski, Jascha Achterberg, et al.
Respiratory Medicine|August 16, 2021
Genomic biomarkers in chronic beryllium disease and sarcoidosisNancy W Lin, Lisa A Maier, Margaret M Mroz, et al.
Gene|October 11, 2025
Genome-wide association study and HLA genotyping for beryllium disease susceptibility in a European descent populationShu-Yi Liao, Tasha E Fingerlin, Sean Jacobson, et al.
Science (New York, N.Y.)|October 31, 2024
Group 2 innate lymphoid cells promote inhibitory synapse development and social behaviorJerika J Barron, Nicholas M Mroz, Sunrae E Taloma, et al.
Immunity|February 9, 2022
Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammationKelly M Cautivo, Peri R Matatia, Carlos O Lizama, et al.
ERJ Open Research|September 25, 2024
AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPDKlaus F Rabe, Fernando J Martinez, Surya P Bhatt, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Lung adventitial fibroblasts support type 2 Tregs to shape the response to influenza infectionAnthony A Chang, Joanna Balcerek, Sofia E Caryotakis, et al.
ESMO Open|August 21, 2025
Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled studyA R Filippi, M R García Campelo, J-B Paoli, et al.
OTJR : Occupation, Participation and Health|June 10, 2021
Stimulating Research to Enhance Aging in PlaceJuleen Rodakowski, Tracy M Mroz, Carrie Ciro, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Physics in Medicine and Biology|December 19, 2024
The textures of sarcoidosis: quantifying lung disease through variogramsWilliam L Lippitt, Lisa A Maier, Tasha E Fingerlin, et al.
Patterns (New York, N.Y.)|April 20, 2026
Organizing across disciplines to tackle shared computational challengesWojtek Treyde, Aleksy Kwiatkowski, Jascha Achterberg, et al.
Respiratory Medicine|August 16, 2021
Genomic biomarkers in chronic beryllium disease and sarcoidosisNancy W Lin, Lisa A Maier, Margaret M Mroz, et al.
Gene|October 11, 2025
Genome-wide association study and HLA genotyping for beryllium disease susceptibility in a European descent populationShu-Yi Liao, Tasha E Fingerlin, Sean Jacobson, et al.
Science (New York, N.Y.)|October 31, 2024
Group 2 innate lymphoid cells promote inhibitory synapse development and social behaviorJerika J Barron, Nicholas M Mroz, Sunrae E Taloma, et al.
Immunity|February 9, 2022
Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammationKelly M Cautivo, Peri R Matatia, Carlos O Lizama, et al.
ERJ Open Research|September 25, 2024
AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPDKlaus F Rabe, Fernando J Martinez, Surya P Bhatt, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Lung adventitial fibroblasts support type 2 Tregs to shape the response to influenza infectionAnthony A Chang, Joanna Balcerek, Sofia E Caryotakis, et al.
ESMO Open|August 21, 2025
Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled studyA R Filippi, M R García Campelo, J-B Paoli, et al.
OTJR : Occupation, Participation and Health|June 10, 2021
Stimulating Research to Enhance Aging in PlaceJuleen Rodakowski, Tracy M Mroz, Carrie Ciro, et al.
Pageof 19